chronic process and could therefore occur during either a haz- ard or control period.
In summary, we found that recent use of thiazide and pos- sibly loop diuretics was associated with a significantly increased risk for recurrent gouty arthritis. Despite the well known association of gout and diuretics, a relatively large pro- portion of our patient population with preexisting gout was prescribed this class of antihypertensive therapy. Given the wide availability of alternative effective agents for the treat- ment of hypertension and congestive heart failure, clinicians have ample ability to individualize management for this pop- ulation, and could reduce risk of recurrent gout attacks by avoiding the use of thiazide and possibly loop diuretics in per- sons with preexisting gout.
Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-99.
Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004;50:2400-14.
Gutman AB. The past four decades of progress in the knowledge of gout, with an assessment of the present status. Arthritis Rheum 1973;16:431-45.
Terkeltaub RA. Clinical practice. Gout. N Engl J Med 2003;349:1647-55.
Wallace SL, Singer JZ. Review: systemic toxicity associated with the intravenous administration of colchicine — guidelines for use. J Rheumatol 1988;15:495-9.
Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg
Incidence and risk factors for gout in white men. JAMA 1991;266:3004-7.
Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ. Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum 1995;38:628-32.
Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421-6.
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004;363:1277-81.
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093-103.
Oren B, Rich M, Belle M. Chlorothiazide (Diuril) as a hyperuricacidemic agent. JAMA 1958;168:2128-9.
Hunte , et al: Diuretics and recurrent gout
Laragh JH, Cannon PJ, Stason WB, Heinemann HO. Physiologic and clinical observations on furosemide and ethacrynic acid. Ann NY Acad Sci 1966;139:453-65.
Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005;165:742-8.
Gurwitz JH, Kalish SC, Bohn RL, et al. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol 1997;50:953-9.
Waller PC, Ramsay LE. Predicting acute gout in diuretic-treated hypertensive patients. J Hum Hypertens 1989;3:457-61.
Rott KT, Agudelo CA. Gout. JAMA 2003;289:2857-60.
Grodzicki T, Palmer A, Bulpitt CJ. Incidence of diabetes and gout in hypertensive patients during 8 years of follow-up. The General Practice Hypertension Study Group. J Hum Hypertens 1997;11:583-5.
Izzo JL Jr. Hypertension in the metabolic syndrome and diabetes: pathogenesis, clinical studies, and treatment. J Clin Hypertens 2003;5 Suppl 4:3-10.
Salvetti A, Ghiadoni L. Guidelines for antihypertensive treatment: an update after the ALLHAT study. J Am Soc Nephrol 2004;15 Suppl 1:S51-S54.
Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
Mosby’s Drug Consult. Top 200 most prescribed drugs of 2003. New York: Elsevier; 2003. [Internet]. Available from: http://www.mosbysdrugconsult.com/DrugConsult/Top_200/. Accessed April 6, 2006.
Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
Wolfram G, Colling M. [Total purine content in selected foods.] Z Ernahrungswiss 1987;26:205-13.
Greenland S. A unified approach to the analysis of case-distribution (case-only) studies. Stat Med 1999;18:1-15.
Tykarski A. Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron 1991;59:364-8.
Malawista SE, Van Blaricom G, Cretella SB, Schwartz ML. The phlogistic potential of urate in solution: studies of the phagocytic process in human leukocytes. Arthritis Rheum 1979;22:728-36.
Ferdinand KC. Recommendations for the management of special populations: racial and ethnic populations. Am J Hypertens 2003;16(11 Pt 2):50S-54S.